Metraipolis › archive › dc_c13018ada2cb

CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation — Europe PMC PMID:41488303

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41488303
DOI
10.3389/fmicb.2025.1725247
License (as archived)
solo-consultazione
Archived
2026-11-07T12:37:27.193Z
SHA-256 of the archived text
859147d8d2e954a0b3ff91bcabe981a9c28cd733da48023f0cd35ff37706d570
Stable URL of this page
https://metraipolis.com/documento/dc_c13018ada2cb

How to cite

CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation — Europe PMC PMID:41488303 — Europe PMC (en), https://europepmc.org/article/MED/41488303 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c13018ada2cb (Metraipolis archive dc_c13018ada2cb, sha256 859147d8d2e954a0b3ff91bcabe981a9c28cd733da48023f0cd35ff37706d570)
BibTeX
@misc{dcc13018ada2cb,
  title = {CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation — Europe PMC PMID:41488303},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41488303},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c13018ada2cb; sha256 859147d8d2e954a0b3ff91bcabe981a9c28cd733da48023f0cd35ff37706d570},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488303. Agents can read the archived copy with the MCP tool read_document.